Rain Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
November 10, 2022 at 04:06 pm EST
Rain Therapeutics Inc. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported net loss was USD 18.04 million compared to USD 18.43 million a year ago. Basic loss per share from continuing operations was USD 0.68 compared to USD 0.7 a year ago.
For the nine months, net loss was USD 53.05 million compared to USD 33.41 million a year ago. Basic loss per share from continuing operations was USD 2 compared to USD 1.96 a year ago.